seed
Stage
2019
Founded
1
Investors
About
Altay Therapeutics develops oral small molecule inhibitors targeting transcription factors for the treatment of serious diseases such as facioscapulohumeral muscular dystrophy (FSHD), cancer, and chronic inflammatory conditions.
Explore Altay Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.